Transition Therapeutics, Inc. (TTHI) Reports Q2 Loss of $0.15, Had No Revenue

Transition Therapeutics, Inc. (NASDAQ: TTHI) reported Q2 EPS of ($0.15), versus $0.22 reported last year. Revenue for the quarter came in at $0 , versus $9.4 million reported last year.

For earnings history and earnings-related data on Transition Therapeutics, Inc. (TTHI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance